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ABSTRACT 
The Ashkenazi Jewish population has up to a 2.5% (1 in 40) carrier frequency for any of the 
three founder mutations in the BRCA1 and BRCA2 genes. The current standard of care suggests 
genetic testing for founder mutations in only those individuals with a personal or family history 
of BRCA-related cancers in addition to Ashkenazi Jewish ancestry; however, recent studies 
suggest that up to 51% of Ashkenazi Jewish BRCA mutation carriers have little or no family 
history of relevant cancers (Gabai-Kapara et al., 2014). Since there are currently no well-defined 
educational programs to address this problem, the purpose of this study was to design, 
implement, and evaluate the utilization of group genetic counseling and pre-counseling education 
among “low-risk” Ashkenazi Jewish individuals being offered genetic testing for BRCA founder 
mutations. Most participants showed a gain in knowledge after group genetic counseling, no 
negativity towards group genetic counseling, and a better understanding of BRCA mutations in 
the Ashkenazi Jewish population. The results of this study show that pre-counseling education 
can be effectively utilized in a group setting and that group genetic counseling can be utilized 
successfully for population screening.  
KEYWORDS: cancer, low-risk, genetic counseling, Ashkenazi, Jewish, group counseling, group 
genetic counseling, pre-counseling education, BRCA 
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INTRODUCTION 
Approximately 12% (1 in 8) of women in the United States will develop breast cancer in her 
lifetime. Of these, 5-10% may carry inherited mutations, the majority of which occur in the 
BRCA1 and BRCA2 genes. The general population has an approximately 0.25% (1 in 400) carrier 
frequency for mutations in either gene. The Ashkenazi Jewish (AJ) population has a 2.5% (1 in 
40) carrier frequency for any of the three known founder mutations in either gene: BRCA1 
185delAG, BRCA1 5382insC, and BRCA2 6174delT (Gabai-Kapara et al., 2014; Levy-Lahad, 
1997). The current standard of care suggests genetic testing for founder mutations only in those 
individuals with a personal or family history of BRCA-related cancers in addition to AJ ancestry. 
Despite the high penetrance of cancer risk with BRCA mutations, recent studies suggest up to 
51% of AJ BRCA carriers have little or no family history of relevant cancers (Gabai-Kapara et 
al., 2014). As this cohort would not meet current guidelines for BRCA testing, it is clear that 
current guidelines do not ascertain a large proportion of Ashkenazi Jews with actionable BRCA 
mutations. 
There is currently debate over whether population screening for BRCA mutations is appropriate. 
Some feel the risks of such screening, including uncertain cancer risks, variants of unknown 
significance, monetary cost, and logistical complications of screening a very large population in 
whom BRCA mutations are relatively rare, makes it inadvisable (Levine & Steinberg, 2015). 
However, the AJ population is uniquely situated for population screening. Three founder 
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mutations account for most deleterious BRCA mutations (~95%), the population is relatively 
small, and the carrier frequency is roughly ten times higher than that of the general population. 
The BRCA Community Study, an initiative implemented by the Program for Jewish Genetic 
Health through Albert Einstein College of Medicine and Montefiore Health System, is a pilot 
program designed to address the high incidence of founder mutations in the AJ population by 
exploring the feasibility of population screening in this community. The BRCA Community 
Study is enrolling individuals of Ashkenazi Jewish descent and, based on reported family 
histories, categorizing them into high-risk and low-risk groups. High-risk individuals are defined 
as having personal or family histories of BRCA-related cancers and are offered traditional genetic 
counseling and genetic testing. Low-risk individuals are invited to a group genetic counseling 
session and offered genetic testing. 
Our study seeks to support and enhance the BRCA Community Study by reviewing previous 
studies on the implementation of written materials, pre-counseling education, and group genetic 
counseling; assessing which areas lacked exploration; and assisting in developing the written 
materials and structure for the group genetic counseling sessions.  
Background 
Written Materials 
Patient research in other areas of population screening, including newborn screening, suggest 
proven methods by which to optimize the patient-friendliness of written materials used to 
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supplement patient education. In a broad overview of newborn screening brochures, Arnold et al. 
(2006), identified several measures by which to evaluate the patient-friendliness of written 
educational materials. These included readability (measured with a Flesch reading ease formula, 
with a 5th grade reading level receiving the highest score), easy-to-read layout (defined in part by 
larger font, avoidance of certain fonts, use of white-space, and visually organized content), clear 
illustrations serving a demonstrated purpose, clear message communication, a manageable 
amount of information, and cultural appropriateness (Arnold et al., 2006).  
A qualitative study by Davis et al. (2006) suggested patients prefer the use of written material to 
accompany oral education as well as user-friendly presentations of relevant information in an 
easy to read format. The study surveyed patient and provider knowledge and awareness of 
newborn screening using focus groups and individual interviews. Patients uniformly indicated 
they would prefer to see concise information with fewer details and they wanted the written 
information to mirror information given to them orally.  
Pre-Counseling Education 
Many models of delivering patient education have been explored. One such model is to provide 
education to patients prior to genetic counseling sessions. Pre-counseling education allows the 
participants in group genetic counseling sessions to attain a similar education level prior to 
entering a session (Albada et al., 2011; Green et al., 2001; Wang et al., 2005). Green et al. (2001) 
assessed the effectiveness of utilizing a pre-counseling interactive computer program in teaching 
women about genetics and breast cancer and concluded that instituting pre-counseling education 
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alleviated fear of embarrassment from lack of knowledge and optimized counseling sessions. A 
study by Wang et al. (2005) measured the effects of pre-counseling educational software and 
concluded that pre-counseling education allowed the participants to gain the same knowledge in 
less time and alleviated patients’ feelings of being overwhelmed. This resulted in shorter genetic 
counseling sessions with no negative effects on patient education and allowed counselors to 
focus on areas requiring clarification.  
Previous studies (Axilbund et al., 2005; Joseph et al., 2010) suggest presenting the same content 
using a variety of methods improves patient understanding. This variety may include group 
discussions, printed materials, and non-interactive slideshow presentations. It has been suggested 
that certain methods may be more accessible to patients because they require a lower degree of 
patient literacy and technology competency than computer-based methods (Axilbund et al., 
2005). 
Group Genetic Counseling 
Group counseling is one of several service delivery models in genetic counseling. Though the 
use of group genetic counseling (GGC) to address risks for hereditary cancer is relatively new, 
Ridge et al. (2009) have shown it to be a well-accepted method among patients. Ridge et al. 
(2009) investigated the utility of GGC specifically among patients whose indication was 
hereditary breast and ovarian cancer. The major questions in this study considered patient 
receptiveness to GGC rather than individual counseling, effectiveness of patient education with 
GGC, and the efficiency of GGC as compared to individual counseling. The group sessions were 
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designed to address all aspects of an individual session and incorporated the information 
traditionally provided during individual genetic counseling sessions through multiple forms of 
media, namely video and slideshow presentations. The counseling component of  an individual 
session was provided through a facilitated group discussion where participants were invited to 
raise questions and concerns or share personal experiences or reactions to the information 
provided. This introduced a variation of the counseling aspect not typically seen in group genetic 
counseling (Ridge et al., 2009).  
The sessions in the study conducted by Ridge et al. (2009) were evaluated based on three factors: 
receptivity to GGC sessions, effectiveness of group counseling, and efficiency of the group 
sessions. It was shown there are distinct advantages inherent in group genetic counseling. Most 
notably, these include the benefit of a shared experience among patients and increased efficiency 
allowing for a greater number of patients to be seen. It was observed that most participants 
seemed comfortable in a group setting and were willing to share personal information. This study 
also identified disadvantages inherent in GGC, including challenging group dynamics, including 
differences in demographics, and group influence on decision-making. With regard to the 
complexities of maintaining a beneficial group dynamic, the authors cite ensuring group 
homogeneity as a technique to reduce in-group conflict (Ridge et al., 2009).  
Population Screening 
While the practice of population screening for autosomal dominant, variably penetrant conditions 
such as cancer predisposition is novel, the practice of population-based screening for autosomal 
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recessive conditions (e.g., Tay-Sachs disease, phenylketonuria, etc.) has existed for decades in 
the form of ethnic-based carrier screening and newborn screening. The success of population-
based carrier screening programs historically has strongly depended on the goodwill and 
education of an engaged community. The Dor Yeshorim screening program in the Orthodox 
Jewish community and the 1971 National Health Strategy, which developed into state-mandated 
genetic testing for sickle cell in the African American community, were population screening 
programs done with and without the support of the communities they were meant to serve. The 
historical success and failure, respectively, of these two programs depended heavily on their 
acceptance and integration into the communities they were meant to serve (Wailoo & Pemberton, 
2006).  
Previous research acknowledges there is a high rate of acceptance in the current AJ population 
for carrier screening for recessive genetic conditions. Shkedi-Rafid et al. (2012) found this 
acceptance appears to extend to BRCA screening. Shkedi-Rafid et al. postulate the use of BRCA 
testing on a population scale may make pre-test counseling so impractical (due to restraints on 
cost, time, and qualified professionals) as to be unrealistic. They call for the development of an 
alternative solution. 
Purpose of Study 
Currently, there are no well-defined educational programs or genetic counseling models designed 
to accommodate the educational and counseling needs of offering genetic testing for BRCA1 and 
BRCA2 founder mutations on a population-wide scale. The purpose of this study was to design, 
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implement, and evaluate the utilization of group genetic counseling and pre-counseling education 
among “low-risk” AJ individuals being offered genetic testing for BRCA founder mutations. 
MATERIALS AND METHODS 
Ethical Considerations 
This study was approved under the Einstein IRB #2014-3174 as a part of the larger BRCA 
Community Study.  
Participants 
Individuals who were accepted to participate in the low-risk arm of the BRCA Community Study 
were invited to take part in this study at the time of the group genetic counseling session. 
Potential participants were advised about the authors and purpose of this study and the pre- and 
post-counseling surveys were explained.  Stratification of risk was determined by the BRCA 
Community Study genetic counselors and all participants of AJ descent with no personal or 
family history of BRCA-related cancers were designated to be part of the low-risk arm of the 
study. The low-risk patients attended twice monthly group genetic counseling sessions conducted 
by genetic counselors at one of two locations within the Montefiore Hospital System. The four 
group genetic counseling sessions were executed during February and March of 2015. 
Individuals under age 25 were not accepted to take part in the BRCA Community Study. All 
were English speaking, had at least one grandparent of Ashkenazi Jewish descent, and had never 
been tested for BRCA mutations. 
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Method 
Pre-counseling Education 
All BRCA Community Study participants categorized as “low-risk” were e-mailed a written 
educational packet designed by the BRCA Community Study prior to attending the group genetic 
counseling session. This packet contained information identical to that presented during the 
group genetic counseling sessions, including information about Ashkenazi BRCA mutations, 
risks associated with being a BRCA mutation carrier, testing for BRCA mutations, and preventive 
measures for carriers.  
Group Genetic Counseling  
The development of the educational tool utilized during the group genetic counseling sessions 
was completed in three phases: original development, revision, and a trial session followed by 
further revision. All phases of development involved the authors of this study in addition to the 
genetic counselors and study coordinators affiliated with the BRCA Community Study. The tool 
was comprised of a 34-slide PowerPoint presentation, which included education about BRCA 
mutations, two facilitated discussion components as well as the genetic testing consenting 
process and information regarding the BRCA Community Study. The broad themes of the 
educational component included the role of BRCA1 and BRCA2 mutations in cancer 
development, preventive options for BRCA carriers, the frequency of BRCA mutations in the 
Ashkenazi Jewish population, and the risks, benefits, and limitations of BRCA testing. 
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Using the guidelines suggested in the literature, the educational tool was organized with patient-
friendliness in mind. Educational information was presented concisely, utilizing easily 
understood images and accessible color schemes and fonts. In order to preserve a therapeutic 
atmosphere, the educational tool included two opportunities for the genetic counselor(s) to lead 
the participants in group discussions of colloquial understandings of BRCA and feelings 
associated with pursuing genetic testing. The first facilitated discussion component was placed at 
the beginning of the session as a facsimile of the opening contracting that takes place between 
genetic counselor and patient during an individual session. The genetic counselor posed the 
question, “What is the first thing that comes to mind when you hear BRCA?” and wrote 
responses on a board for participants to see and discuss with the group. The second facilitated 
discussion component was placed at the end of the session to replicate the discussion a genetic 
counselor and patient would typically have regarding attitudes and feelings about the prospect of 
genetic testing in an individual session. Participants were asked to anonymously write a one-
word description of their feelings on an index card and give the cards to the genetic counselor(s). 
The feelings described by the participants were addressed by the genetic counselor(s) and made 
available for discussion within the group.  
In addition to the original development and revision process of creating the educational tool, a 
trial session was conducted with the authors of this study and the genetic counselors associated 
with the BRCA Community Study, in order to identify further areas for improvement and 
generate potential answers to the facilitated discussion questions to aid future participants who 
might struggle to take part in the group activities. 
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Measures  
Information was collected via self-administered surveys conducted immediately prior to and 
following each low-risk group genetic counseling session. Items included in the surveys were 
constructed following a review of the literature, which identified key contributors to the efficacy 
of group genetic counseling, such as knowledge and patient comfort. The genetic counselors 
associated with the BRCA Community Study were consulted to provide expertise and advice in 
targeting the issues most pertinent for investigation.  
Knowledge 
Participants’ knowledge of the informational material covered during the group genetic 
counseling sessions was measured in two parts, by the pre- and post-counseling surveys. The 
surveys each contained five identical knowledge-based questions to measure prior knowledge as 
well as knowledge gained after the session. These questions assessed the participants’ 
understanding of the broad themes included in both the pre-counseling education and group 
genetic counseling sessions. Examples of knowledge-based questions included in the surveys are 
“Who can be at risk to carry BRCA mutations?” (inheritance of BRCA mutations), “How does 
the risk for Ashkenazi Jews to carry a BRCA mutation differ from the general 
population?” (founder mutation frequency), “True or false: If someone is a BRCA carrier, he/she 
will definitely develop cancer” (risks for BRCA-related cancers), and “Individuals who are 
BRCA carriers can __________” (preventive measures available to carriers). 
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Patient Comfort 
Participants’ comfort in the group setting was measured by three questions on the post-
counseling survey. Participants were required to rate the extent to which they agreed with the 
first question, “I would have rather have met one-on-one with a genetic counselor.” on a 5-point 
Likert scale ranging from “strongly agree” to “strongly disagree.”  
The second question required participants to describe their feelings about the group setting. 
Patient comfort in this setting was evaluated to ascertain whether group dynamics influenced 
individual decision making regarding genetic testing. The question, “Did the group setting make 
you feel intimidated or pressured in any way?” was answered by rating their feelings of 
intimidation or pressure on a scale including either, both, or neither feelings, e.g., “I felt 
intimidated,” “I felt pressured to get tested,” “I felt both intimidated and pressured to get 
tested,” and “I felt neither intimidated nor pressured.”  
  
The third question required participants to describe their feelings about engaging in the 
facilitated discussion aspects of the session. The question, “How do you feel about the 
‘interactive’ elements of the session?” was answered by checking all applicable answers. These 
included, “I felt comfortable participating,” “I did not feel comfortable sharing my feelings in 
public,” “I did not think it was a valuable part of the session,” and “It enhanced my experience 
being in a group.” 
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Pre-counseling Education Utilization 
Participants were required in the pre-counseling survey to answer whether they had read the pre-
counseling fact sheet. In the post-counseling survey, participants were asked to describe their 
perception of its efficacy, as described below. 
Patient Perception of Group Counseling and Pre-counseling Education Efficacy 
Participants’ perceptions of the efficacy of both the pre-counseling education and the group 
counseling session were assessed by one question on the post-counseling survey. The question 
required participants to describe their feelings about the usefulness of the pre-counseling 
education and the group genetic counseling session. The statement, “I feel that I have a better 
understanding of BRCA in the Ashkenazi population now than I did before the session.” was 
answered by rating feelings on a scale. Possible answers included, “Yes. I read the materials in 
advance, but today made everything much clearer,” “Yes. I did not read the educational 
materials in advance,” “No. This was redundant of the information available before I came 
today,” and “No. I still do not have a clear understanding of this topic.” 
 An area for additional freeform feedback was provided on the post-counseling survey. 
RESULTS 
The pre-counseling and post-counseling surveys were administered to 11 individuals who 
particpated in the four low-risk sessions in February and March of 2015. All participants 
consented to the surveys prior to beginning the group genetic counseling sessions. Participants 
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attended low-risk group genetic counseling sessions conducted by genetic counselors associated 
with the BRCA Community Study. Of the four group genetic counseling sessions administered, 
one group had four participants, one had five participants, and two had one participant each.  
Table I lists results for the general demographic information collected.  
Pre-counseling Education Utilization 
When participants were asked if they had read the educational packet provided to them prior to 
the group genetic counseling session, six (55%) indicated they had read the packet while five 
(45%) had not.  
Knowledge 
Table II presents the number of individuals who answered the knowledge-based questions 
correctly on the pre-counseling and post-counseling survey. The participants’ answers to the 
knowledge component of the pre-counseling and post-counseling surveys can be referred to in 
Table II. The average pre-counseling score was 79.5% while the average post-counseling score 
was 95.5%.  
Patient Comfort 
Two participants did not answer these questions as they each attended the group genetic 
counseling sessions as the only participant, nulling their answers for the purpose of assessing 
patient comfort during a group genetic counseling session.  
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When asked if the participants would prefer to meet with a genetic counselor one-on-one, 4/9 
(44%) reported they felt neutral, 4/9 (44%) reported they disagreed and would not prefer to meet 
with a genetic counselor one-on-one, and one (11%) reported they strongly disagreed. No 
participants reported they would prefer to meet with a genetic counselor one-on one.  
When asked if the group setting made you feel intimidated or pressured in any way, 9/9 (100%) 
participants answered they felt neither intimidated nor pressured during the group genetic 
counseling session.  
Participants were asked to score their feelings about participating in the interactive elements of 
the session: 7/9 (78%) reported feeling comfortable participating, 1/9 (11%) reported it enhanced 
the experience of being in a group, and 1/9 (11%) reported both they felt comfortable 
participating and it enhanced the experience of being in a group.   
Patient Perception of Group Counseling and Pre-counseling Education Efficacy 
Participants were asked if they felt they had a better understanding of BRCA in the Ashkenazi 
population now than before the session. Of the 11 participants, six (55%) reported they felt they 
had a better understanding of the information and they had read the educational pamphlet prior to 
the session, four (36%) reported they felt they had a better understanding of the information and 
they had not read the educational pamphlet prior to the session, one (9%) reported they did not 
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read the packet and did not feel they had a better understanding after the session as the 
information presented was redundant to information available before the counseling. 
Facilitated Discussion 
Participants’ responses to the first discussion question “What is the first thing that comes to 
mind when you hear BRCA?” can be found in Table III. Most individuals suggested a type of 
cancer or Angelina Jolie. Participants’ responses to the second discussion question “How are 
they feeling about genetic testing?” can be found in Table III. Most individuals identified their 
feelings on a spectrum of readiness for testing, ranging from ready to unsure. No participants 
provided additional freeform feedback on the post-counseling surveys. 
DISCUSSION 
This study aimed to evaluate the design and implementation of group genetic counseling and pre-
counseling education among “low-risk” AJ individuals being offered genetic testing for BRCA 
founder mutations through the BRCA Community Study by measuring knowledge gain, patient 
comfort and patient perception of efficacy.  
Pre-counseling education has previously shown reinforcement of information for clients and 
increased counselor efficiency during a cancer counseling session (Axilbund et al., 2005). 
However, this theory has only been explored with regard to individual genetic counseling 
sessions. The results of this study show approximately half of the participants indicated they read 
the educational packet and felt they had a better understanding of BRCA in the AJ population 
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after the session than before it and approximately half of the participants indicated they had not 
read the packet. Of the six participants who read the pre-counseling education, all showed a gain 
in knowledge between the pre- and post-counseling surveys. Further investigation is needed to 
determine the knowledge gain solely from the pre-counseling education and whether it truly 
increases counselor efficiency.  
It was notable that of the five participants who did not read the pre-counseling education, three 
showed a gain in knowledge on the pre- and post-counseling surveys and two showed a high 
baseline of knowledge on the pre-counseling surveys  (i.e., answering all knowledge questions 
correctly) with no improvement or regression on the post-counseling surveys. These results 
could indicate the efficacy of the group genetic counseling sessions and a relatively high level of 
awareness and knowledge of BRCA in the population from which the participants were drawn. 
Group genetic counseling for patients at increased risk for hereditary breast and ovarian cancer 
due to a positive family history has previously been studied with regard to patient comfort and 
patient knowledge. Applying group genetic counseling to population screening, where each 
individual enters the genetic counseling session with an identical risk to carry a BRCA founder 
mutation, however, is novel. Our results show a gain in knowledge for all patients from the pre-
counseling survey to the post-counseling survey. With regard to measures of patient comfort, all 
respondents who took part group sessions (n=9) indicated they felt neither pressured nor 
intimidated by the group setting and that the facilitated discussion components of the sessions 
were comfortable to participate in, enhanced the group experience, or both. No participants 
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reported preferring to have met individually with a genetic counselor with 44% reporting neutral 
feelings and 55% disagreeing or strongly disagreeing with preferring an individual meeting. One 
likely contributing factor to the strong trend towards patient comfort was the relative 
homogeneity of the groups. In addition to being of AJ descent and at a 1 in 43 risk to carry a 
founder mutation, all individuals had achieved at least a Bachelor’s degree as their highest level 
of education and lived in the greater New York area. Of course, there is still a question of the 
effects of group heterogeneity due to age and possible differences in healthcare-seeking 
behaviors and traditions among different sects of Judaism on patient comfort. The global gain in 
knowledge and strongly rated patient comfort suggest that using this model of group genetic 
counseling for BRCA population screening is a practical framework for providing successful pre-
test counseling to patients.  
This study had several limitations. The most notable of these is the small sample size. Although 
the BRCA Community Study received a positive response from the community, many more 
participants in their study were designated “high-risk” than expected. The relatively low number 
of “low-risk” participants, combined with the limited duration of this study, contributed to the 
limited sample size. To preserve time, the length of the surveys was restricted and this created 
limitations to the scope of this study such that participants’ reasons for not reading the packet 
were not identified and the structure of the surveys, could not ascertain whether participants felt 
they gained the most knowledge from the pre-education packet, the group session, both, or 
neither. Additionally, further study could determine which aspects of the pre-counseling 
education (i.e., repetition of material, higher baseline knowledge, or obtaining information 
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through more than one modality) were most valuable in contributing to gain in knowledge. 
Another limitation lies in the lack of ascertainment with regard to why so many participants 
chose not to read the educational packet. Gaining a better understanding of participants’ reasons 
for not reading the packet would help facilitate further revisions and improvements in patient-
friendliness.  
In the interest of optimizing the time used during the group genetic counseling sessions, our pre- 
and post-surveys were designed to be as concise as possible. In achieving this, certain 
demographic information including gender identification, sexual orientation, marital status, and 
parental status was not collected. Therefore, although our participants’ responses may be 
generalizable to individuals of the same age groups and education levels, this study is unable to 
draw conclusions about the differences in experiences and understanding engendered by 
membership in different identity groups. Additionally, all participants in this study achieved a 
relatively high level of education, making them more likely to easily understand information 
about genetic testing. Their comfort in the group setting and ease in gaining knowledge about 
BRCA may not be applicable to individuals with different levels of education.  
The results of this study show a broadly positive patient experience utilizing group genetic 
counseling as a service delivery model for pre-test counseling in terms of knowledge gain, 
patient comfort, and patient perceptions of efficacy. However, further research is necessary to 
evaluate the effects of this model with larger numbers of individuals of different demographic 
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and cultural backgrounds to gain a better understanding of its true impact on patient knowledge 
and comfort.  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